This document discusses how the legal doctrine of preemption can provide a defense against product liability claims for generic drug manufacturers. Preemption arises when federal law supersedes state law, including when a state lawsuit would force a defendant to violate federal regulations. The document examines a recent case where preemption was used as a defense, noting that generic drug manufacturers cannot unilaterally change labeling approved by the FDA.